(IN BRIEF) Researchers at Empa have developed a revolutionary process for producing high-quality piezoelectric thin films at low temperatures using the Synchronized Floating Potential HiPIMS (SFP-HiPIMS) method. This process enables the production of piezoelectric films on insulating substrates, which are … Read the full press release
Posted in Business, Energy, Gas & Oil, Financial, Industrial, Investment, Management, Marketing, News, Science, Switzerland, Technology
Tagged electronic components, Empa, high-tech manufacturing, HiPIMS, ion acceleration, low-temperature processing, nanotechnology, photonics, piezoelectric thin films, quantum technologies, semiconductor, SFP-HiPIMS, thin film deposition
(IN BRIEF) The Viessmann Foundation has donated €5.6 million to the German Cancer Research Center (DKFZ) to advance research into cancer prevention through nutrition and the development of new treatments for pediatric oncology. This five-year funding will support vital research … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Non Profit, Science, Technology
Tagged Cancer Prevention, cancer research, Cancer Therapies, DKFZ, donation, Fostering Future Generations, Healthcare, Max Viessmann, Michael Baumann, Nutrition, pediatric cancer treatments, pediatric oncology, Viessmann Foundation, Viessmann Generations Group
(IN BRIEF) Roche announced the European Commission’s approval of a label extension for Evrysdi® (risdiplam) to include a new 5mg tablet, offering a room-temperature stable alternative to the original oral solution for individuals with spinal muscular atrophy (SMA). The tablet, … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Switzerland, Technology
Tagged 5mg tablet, bioequivalence, clinical development, clinical study, disease-modifying treatment, European Commission, Evrysdi, family caregivers, label extension, Nicole Gusset, non-invasive treatment, PTC Therapeutics, risdiplam, Roche, SMA, SMA Europe, SMA Foundation, SMA patients, SMN protein, spinal muscular atrophy, treatment flexibility
(IN BRIEF) The European Investment Bank (EIB) has signed a €20 million financing deal with Leyden Laboratories to support the development of its innovative pan-influenza nasal spray, which aims to protect against seasonal and pandemic viral infections. The funding, guaranteed … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, Marketing, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged antiviral protection, avian flu, biodefense, EU4Health, European Commission, European health defense, European Investment Bank, Hadja Lahbib, HERA Invest, influenza, InvestEU, Koenraad Wiedhaup, Leyden Labs, nasal spray, non-vaccine approach, Pandemic Preparedness, partnership, respiratory viruses, Robert de Groot, sustainability
(IN BRIEF) Rilzabrutinib, an oral Bruton’s tyrosine kinase (BTK) inhibitor, has received orphan drug designation from the U.S. FDA for sickle cell disease. This marks the fourth such designation for the drug, which has already been recognized for its potential … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged BTK inhibitor, fast track status, FDA, IgG4-related disease, immune thrombocytopenia, multi-immune modulation, orphan drug designation, preclinical data, rare diseases, rilzabrutinib, Sanofi, sickle cell disease, Tailored Covalency®, vaso-occlusive crises, warm autoimmune hemolytic anemia
(IN BRIEF) A study by the University of Helsinki has uncovered why some breast cancer treatments, including immunotherapy, may not be effective for all patients. The research, focusing on the mechanical properties of tumor tissue, shows that softer tissue environments … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged breast cancer, cancer research, cancer treatment, Finland, global research collaboration, HUS Helsinki University Hospital, immunotherapy, Kymenlaakso Health, MD-PhD student Aino Peura, Nature Communications, personalized medicine, tissue microenvironment, tumor progression, University of Helsinki
(IN BRIEF) Emmanuel Adjei, a sports scientist at TUM, embarks on a 10,000-kilometer charity ride from Munich to Accra to promote educational equity and raise funds for the NGO EduSpots. Starting on June 7, 2025, the journey will cover 15 … Read the full press release
Posted in Business, Education, Financial, Germany, Industrial, Investment, Management, News, Non Profit, Science, Society, Sports, Technology
Tagged access to education, Africa, Bike2MyRoots, charity ride, cycling journey, educational equity, EduSpots, Emmanuel Adjei, Equal opportunities, fundraising, GHANA, Munich to Accra, Sports Science, TUM University Hospital, women’s education
(IN BRIEF) A study led by TUM and supported by the University of Oxford has revealed that producing green hydrogen in Africa for export to Europe is much more expensive than previously assumed. Only a small fraction of potential production … Read the full press release
Posted in Business, Education, Energy, Gas & Oil, Environment, Financial, Germany, Government, Industrial, Investment, Management, News, Science, Technology
Tagged Africa, climate-compatible growth, Emissions Reduction, Europe, financing costs, GREEN HYDROGEN, green transition, hydrogen production, off-take agreements, partnership, policy intervention, price guarantees, renewable energy, sustainability, sustainable development, TUM, University of Oxford
(IN BRIEF) Newcastle University’s Discover Festival, a free family-friendly event, will take place on Saturday, June 7, 2025, offering a day of interactive learning and entertainment. Over 70 activities will showcase the university’s pioneering research, including hands-on experiences in robotics, … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Entertainment, Financial, Industrial, Investment, Management, Marketing, Media, News, Science, Technology, United Kingdom
Tagged AI, chemical reactions, community event, Discover Festival, Education, family-friendly, food festival, interactive activities, Mind-Controlled Machines, musical performances, Newcastle University, RESEARCH, Robo Rally, robotics, STEM activities, university events
(IN BRIEF) Researchers at Newcastle University have discovered a new biological mechanism explaining why some patients do not respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors. They identified T regulatory cells (Tregs) as key drivers of ICB … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged anti-CD30, Brentuximab Vedotin, Cancer Immunotherapy, cancer research, combination treatment, ICB resistance, immune checkpoint blockade, immunotherapy breakthroughs, lung cancer, melanoma, metastatic cancer, Newcastle University, pancreatic cancer, PD-1, skin cancer, solid tumors, T regulatory cells
(IN BRIEF) The University of Glasgow has appointed Professor Emma Thomson as the new Director of the MRC-University of Glasgow Centre for Virus Research (CVR), after she served as Interim Director from February. An expert in emerging infectious diseases, Professor … Read the full press release
Posted in Education, Healthcare, Science, Technology, United Kingdom
Tagged Centre for Virus Research, COVID-19, CVR, emerging viruses, Glasgow medical research, global health, hepatitis, infectious diseases, MRC, Pandemic Preparedness, Professor Emma Thomson, public health, scientific leadership, University of Glasgow, vaccine trials, viral research, virology
(IN BRIEF) Novartis has announced that its Phase III PSMAddition trial of Pluvicto™ in combination with standard of care (SoC) has met its primary endpoint, showing a significant benefit in radiographic progression-free survival (rPFS) and a positive trend in overall … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged androgen receptor pathway inhibitors, cancer research, clinical trials, FDA approval, FDA regulatory review, metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer, mHSPC, Novartis, Novartis oncology, overall survival, Phase III PSMAddition, Pluvicto, progression-free survival, prostate cancer, prostate cancer treatment, PSMA-positive, radioligand therapy, treatment options
(IN BRIEF) Novartis has presented new data from the Phase III NATALEE trial at ASCO 2025, showcasing Kisqali’s ability to reduce the risk of recurrence in pre-menopausal patients with high-risk early breast cancer. The data reveals a 33% reduction in … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged adjuvant treatment, ASCO 2025, Black patients, Breast Cancer Treatment, CDK4/6 inhibitors, DDFS, disparities in healthcare, early breast cancer, EBC, endocrine therapy, HR+/HER2-, invasive disease-free survival, Kisqali®, metastatic breast cancer, Novartis, Phase III NATALEE, post-menopausal, pre-menopausal, recurrence-free survival, RFS, ribociclib, Risk Reduction, survival benefit
(IN BRIEF) Eckert & Ziegler successfully hosted the 3rd annual Boston Radionuclide Theranostics Forum, bringing together industry leaders to discuss radionuclide theranostics’ role in transforming precision oncology. The event featured expert presentations on advancements in radiopharmaceuticals, clinical development challenges, and … Read the full press release
Posted in Berlin, Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Pharma & Biotech, Science, Technology
Tagged Boston Radionuclide Theranostics Forum, clinical development, Dr. Harald Hasselmann, Eckert & Ziegler, German American Business Council, Industry innovation, Morrison Foerster, nuclear medicine, patient access, precision oncology, radionuclide theranostics, radiopharmaceutical community, radiopharmaceuticals, radiotherapy, Solomon Partners
(IN BRIEF) Fresenius Medical Care will showcase a variety of new research at the 62nd Congress of the European Renal Association (ERA) in Vienna, focusing on advancements in kidney care, artificial intelligence, fluid management, and hemodiafiltration. Key studies include the … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Science, Technology
Tagged AI, Andrea Nandorine Ban, artificial intelligence, CONVINCE trial, dialysis, ERA Congress, fluid management, Frank Maddux, Fresenius Medical Care, hemodiafiltration, hemodialysis, kidney disease, medical advancements, nephrology, patient outcomes, Renal Research Institute, RESEARCH
(IN BRIEF) Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduced relapse rates and prevented disability progression in patients with relapsing multiple sclerosis (RMS). The study revealed an annualized relapse … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Bruton’s tyrosine kinase, BTK inhibitor, clinical data, clinical research, clinical trial, data, disability, disability progression, fenebrutinib, FENopta, Levi Garraway, multiple sclerosis, Phase II, relapse rates, relapsing multiple sclerosis, RMS, Roche, treatment
(IN BRIEF) Itepekimab, developed by Sanofi and Regeneron, met its primary endpoint in the AERIFY-1 phase 3 study for COPD, showing a 27% reduction in moderate or severe exacerbations at 52 weeks. However, the AERIFY-2 study did not achieve the … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged adverse events, AERIFY-1, AERIFY-2, Chronic obstructive pulmonary disease, clinical trials, COPD, COVID-19, drug efficacy, Exacerbations, IL33, Itepekimab, moderate exacerbations, monoclonal antibody, partnership, phase 3 study, Regeneron, regulatory authorities, research and development, Sanofi, severe exacerbations, therapeutic development
(IN BRIEF) Valio is a key partner in the EU-funded PRIMARY project, which aims to transform agricultural by-products into valuable resources. As part of the project, Valio is exploring grass biorefinery innovations, including using grass juice to fortify feed protein … Read the full press release
Posted in Agriculture, Business, Environment, Estonia, European Union, Financial, Finland, Food & Beverage, Government, Greece, Industrial, Investment, Management, News, Science, Small Business, Technology
Tagged agricultural by-products, bio-based materials, bioeconomy, bioenergy, biorefinery, cotton by-products, dairy farms, Estonia, EU, fermentation, Finland, grass biorefineries, Greece, Horizon Europe, olive residues, partnership, PRIMARY project, protein fortification, protein self-sufficiency, renewable energy, sustainability, Valio, VTT Technical Research Centre
(IN BRIEF) SGS has received approval from OSHA to expand its global network of Nationally Recognized Testing Laboratories (NRTLs) to new locations in Europe and Asia. Starting January 22, 2025, SGS will provide testing and certification for U.S. market products … Read the full press release
Posted in Business, European Union, Financial, Government, Industrial, Investment, Management, Marketing, News, Science, Security & Safety, Switzerland, Technology
Tagged ASME A17.5, Brussels, certification, Elevator and Escalator Electrical Equipment, global network, Gyeonggi-do, international testing, John Ciliege, New Taipei City, North America, NRTL, OSHA, partnership, product compliance, product safety, Puchheim, Safety Standards, SGS, SGS North America Mark, sustainability, testing, U.S. market, Yokohama
(IN BRIEF) SGS has strengthened its support for Canadian farmers by offering extensive seed testing services across the country, combining local expertise with global testing standards. With laboratories in key agricultural regions such as Grande Prairie and Sherwood Park, SGS … Read the full press release
Posted in Agriculture, Business, Environment, Financial, Government, Industrial, Investment, Management, News, Science, Switzerland, Technology
Tagged aging tests, agricultural testing services, Canadian agriculture, cold stress, Crop Science, disease diagnostics, germination rates, global markets, Grande Prairie, Holly Gelech, partnership, planting strategies, regulatory compliance, seed chemistry, seed health, seed testing, seed vigor, SGS, Sherwood Park laboratory, stress tolerance, sustainability
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?